Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3301 to 3315 of 7683 results

  1. Diabetes: annual HbA1c (children) (IND49)

    This indicator covers the proportion of children and young people with diabetes who have had their glycated haemoglobin A1c (HbA1c) monitored in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG67

    Network / system level indicators
    Last updated
    18 May 2023

  2. Health Technology Assessment Innovation Laboratory (HTA Lab)

    NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

  3. NICE and health inequalities

    Our health inequalities guidance supports strategies that improve population health as a whole, while offering particular benefit to the most disadvantaged

  4. Intrabeam radiotherapy system for adjuvant treatment of early breast cancer . Patient decision aid on intrabeam radiotherapy for treating early breast cancer

    Decision aid for Intrabeam radiotherapy system for adjuvant treatment of early breast cancer, TA501 c NICE 2018. All rights reserved. Subject to...

  5. Study NICE and LSE's Executive MSc Healthcare Decision-Making

    Study NICE and LSE's Executive MSc Healthcare Decision-Making

  6. Technology appraisal and highly specialised technologies appeals

    Technology appraisal and Highly specialised technologies appeals

  7. Past appeals and decisions

    Down to Rejected appeals Cancelled appeals Past appeals TA ID Appraisal short title Appeal hearing date TBC Afamelanotide for erythropoietic

  8. Kidney conditions: CKD - ACEi and ARB (IND263)

    This indicator covers the percentage of patients on the CKD register and with an albumin to creatinine ratio (ACR) of 70 mg/mmol or more, without diabetes, who are currently treated with an ARB or an ACE inhibitor. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM247

    General practice indicators suitable for use outside of QOF
    Published
    21 August 2023

  9. NICE Advice service

    NICE Advice is an advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market, and supporting organisations who fund or generate evidence for health technologies.

  10. Technology appraisal submission templates and supporting documents

    On this page, you'll find all the templates and supporting documents you need to make a technology appraisals submission. These templates have been...

  11. Urinary tract infection (lower). Patient decision aid on cystitis: taking an antibiotic

    Cystitis: taking an antibiotic Information to help women who are not pregnant discuss the options with their healthcare professionals. Published...

  12. Managed access

    Managed access allows patients to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.

  13. Artificial intelligence (AI) and digital regulations service

    NICE's leading role in designing a new service to support the development and adoption of AI and data-driven technologies in health and care.

  14. Commercial Liaison Team

    The Commercial Liaison Team (CLT) works with companies who are considering a patient access scheme for their drug or treatment. Patient access schemes

  15. What we do

    Role and responsibilities of the National Institute of Health and Care Excellence